Jubilant Life Sciences is currently trading at Rs. 642.70, up by 5.85 points or 0.92% from its previous closing of Rs. 636.85 on the BSE.
The scrip opened at Rs. 638.40 and has touched a high and low of Rs. 652.00 and Rs. 638.40 respectively. So far 7989 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 879.10 on 12-Apr-2017 and a 52 week low of Rs. 552.40 on 26-Dec-2016.
Last one week high and low of the scrip stood at Rs. 682.00 and Rs. 610.50 respectively. The current market cap of the company is Rs. 10333.36 crore.
The promoters holding in the company stood at 54.02%, while institutions and non-institutions held 24.66% and 21.32% respectively.
Jubilant Life Sciences' a wholly-owned subsidiary -- Drug Discovery and Development Solutions, Singapore (DDDSL) has entered into Stock Purchase Agreement for acquiring entire Equity Share capital of Jubilant Discovery Services Inc., USA (JDSI) on November 21, 2017.
JDSI is a step-down subsidiary whose share capital is held by Jubilant Biosys, a step-down subsidiary of the Company. After the said acquisition of shares, JDSI shall become a wholly-owned subsidiary of DDDSL.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.